69 related articles for article (PubMed ID: 3054462)
1. [References for a blood glucose lowering effect of tritoqualine in insulin treated diabetic patients].
Köbberling J; Cüppers HJ; Hintze G; Richter K; Rommelmann F; Tillil H
Med Klin (Munich); 1988 Sep; 83(18):596-600. PubMed ID: 3054462
[No Abstract] [Full Text] [Related]
2. [Intensified insulin therapy. References for general practice for increased control].
Dreyer M
MMW Fortschr Med; 2000 May; 142(21):42-4, 46, 48 passim. PubMed ID: 10872294
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
Hamet P; Verdy I; Chiasson JL; Verdy M
Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
[TBL] [Abstract][Full Text] [Related]
4. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
5. Twenty-four hour blood glucose profiles during insulin and insulin plus aprotinin subcutaneous administration in type I diabetes.
Lunetta M; Napoli E; Sudano L; Leonardi R; Mughini L
Horm Metab Res; 1986 Mar; 18(3):182-4. PubMed ID: 2422103
[TBL] [Abstract][Full Text] [Related]
6. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
[TBL] [Abstract][Full Text] [Related]
7. [Delayed action insulins. What is the value of insulin glargine in general practice?].
MMW Fortschr Med; 2001 Apr; 143(16):54-6. PubMed ID: 11367996
[No Abstract] [Full Text] [Related]
8. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
[TBL] [Abstract][Full Text] [Related]
9. [Hypoglycemic treatment of type 2 diabetes].
Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
[TBL] [Abstract][Full Text] [Related]
10. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
Johnson JL; Wolf SL; Kabadi UM
Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
[TBL] [Abstract][Full Text] [Related]
12. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
13. [Value of combined subcutaneous infusion of insulin and metformin in 10 insulin-dependent obese diabetics].
Leblanc H; Marre M; Billault B; Passa P
Diabete Metab; 1987; 13(6):613-7. PubMed ID: 3329125
[TBL] [Abstract][Full Text] [Related]
14. Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study.
Davidson JA; Perez A; Zhang J;
Diabetes Obes Metab; 2006 Mar; 8(2):164-74. PubMed ID: 16448520
[TBL] [Abstract][Full Text] [Related]
15. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
Dashora UK; Sibal L; Ashwell SG; Home PD
Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589
[TBL] [Abstract][Full Text] [Related]
16. Variability of blood glucose levels in patients with type 1 diabetes mellitus on intensified insulin regimens.
Moberg EA; Lins PE; Adamson UK
Diabete Metab; 1994; 20(6):546-52. PubMed ID: 7713278
[TBL] [Abstract][Full Text] [Related]
17. Humalog Mix25 offers better mealtime glycemic control in patients with type 1 or type 2 diabetes.
Malone JK; Yang H; Woodworth JR; Huang J; Campaigne BN; Halle JP; Yale JF; Grossman LD
Diabetes Metab; 2000 Dec; 26(6):481-7. PubMed ID: 11173719
[TBL] [Abstract][Full Text] [Related]
18. Sulphonylurea in combination with insulin therapy: does it make sense? A review.
Kyllästinen M
Ann Clin Res; 1983; 15 Suppl 37():29-32. PubMed ID: 6383182
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus management in general practice: where are we?
Staff M
Aust Fam Physician; 1999 Aug; 28(8):775. PubMed ID: 10495524
[No Abstract] [Full Text] [Related]
20. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
